Feature

Perspectives

Creating Value in Cancer Care Through Standardized Metrics and Partnerships Between Patient Navigators and Physicians

04/17/2018

Abstract: While providers and care systems can agree that effective patient navigation programs are essential to positive patient outcomes, there have been no standard metrics that could be used to measure the...

...

04/17/2018

Journal of Clinical Pathways

From the Field

Mock Clinical Pathways: Exploring the Process of Developing a Pathway for Metastatic Breast Cancer

02/15/2018

Bruce A. Feinberg , DO;

Chadi Nabhan , MD, MBA, FACP;

Abstract: Clinical pathways are a critical structural element in the effort to reduce variation in health care delivery, allowing for cost reduction as well as more predictable, measurable, and accountable outcomes. At the 2nd Annual...

Abstract: Clinical...

02/15/2018

Journal of Clinical Pathways

Research Reports

Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment Setting

02/15/2018

Michael A. Savin , MD;

Ravi Salgia , MD, PhD;

Blase Polite , MD;

Corey Shamah , MD;

Mark A. Socinski , MD;

Amanda Barry , MPH;

Kathy Lokay ;

Peter G. Ellis , MD;

Casey Mason ;

Ray Page , DO, PhD, FACOI, FASCO;

Natalie Dickson , MD;

Abstract: Despite clear clinical benefit and guideline recommendations for predictive biomarker testing and subsequent first-line targeted therapy treatment in patients with non–small cell lung cancer (NSCLC), there...

...

02/15/2018

Journal of Clinical Pathways

Research Reports

Costs of Care for Patients Receiving Chemotherapy for Advanced Bladder Cancer

12/13/2017

Xiting Cao , PhD;

Amishi Y. Shah , MD;

Yichen Zhong , MPH;

Ashish M. Kamat , MD, MBBS;

Kyle Flannery , PharmD, MS;

Jinghua He , PhD, MPH;

12/13/2017

Journal of Clinical Pathways

Research Reports

Longitudinal Study of Chronic Kidney Disease Progression and Associated Costs

11/27/2017

Karen J. McGaughey , PhD;

Macaulay Onuigbo , MD, MSc, MBA;

Susan E. Funk , MBA, FACHE;

Nancy L. Reaven , MA;

Alain Romero , PharmD, PhD;

Paula J. Alvarez , RPh, MPH, MBA;

Ladan Golestaneh , MD, MS;

Editor's Note: This article was updated for minor editorial additions and formatting changes, per request of the authors. Abstract: In order to identify drivers of chronic kidney disease (CKD) stage progression and...

...

11/27/2017

Journal of Clinical Pathways

Perspectives

Industry Consolidation Within Clinical Pathways

11/27/2017

Winston Wong , PharmD;

Abstract: Express Scripts recently announced the purchase of eviCore, a leading medical benefits management firm, for $3.6 billion. The merger has the potential to be the first comprehensive care management offering....

...

11/27/2017

Journal of Clinical Pathways

Research Reports

Community Oncologists‚ Perception and Adaptability to Emerging Chimeric Antigen T-Cell Therapy

10/16/2017

Bruce A. Feinberg , DO;

Chadi Nabhan , MD, MBA, FACP;

Yolaine J. Jeune-Smith , PhD;

Peter Klinefelter , BA;

Jennifer Fillman , MBA;

Abstract: The Oncologic Drugs Advisory Committee recently voted 10-0 recommending to the Food and Drug Administration (FDA) the approval of the first chimeric antigen receptor T (CAR-T) therapy. We sought to better...

...

10/16/2017

Journal of Clinical Pathways

Perspectives

Potential for Clinical Pathways in Symptom Management

10/16/2017

Gena Cook , BA;

Abstract: Clinical pathways are one of the main tools employed across health care to manage quality and consistency. Pathways are also useful for the reduction of variability in cancer care. Clinical pathways in...

...

10/16/2017

Journal of Clinical Pathways

Special Article

Clinical Pathways to Address the Challenges of Treatment Resistance and Relapse in Multiple Myeloma

09/19/2017

Executive Summary Multiple myeloma (MM) is caused by abnormal plasma cell growth in bone marrow, resulting in bone destruction, marrow failure, and adverse blood cell production. The course of MM is characterized by...

...

09/19/2017

Journal of Clinical Pathways

Research Reports

The Impact of Decreasing Variability in Surgical Care Through a Structured Multi-Disciplinary Thoracic Oncology Program

09/19/2017

Lynn T. Tanoue , MD;

Shamini Parameswaran , MD;

Anthony W. Kim , MD, MS, FACS, FCCP;

Daniel J. Boffa , MD;

Jia Liu , MD;

Frank C. Detterbeck , MD;

Clinton D. Protack , MD, PhD;

Justin D. Blasberg , MD;

Abstract: In order to identify the impact of decreasing variability in surgical care through a structured multidisciplinary thoracic oncology program (TOP), the researchers observed changes following the...

...

09/19/2017

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Feature

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products